Emcure Pharmaceuticals Stock Current Valuation
| EMCURE Stock | 1,421 33.45 2.41% |
Valuation analysis of Emcure Pharmaceuticals helps investors to measure Emcure Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Fundamental drivers impacting Emcure Pharmaceuticals' valuation include:
Price Book 9.3858 | Enterprise Value 295.8 B | Enterprise Value Ebitda 22.4886 | Price Sales 3.9175 | Trailing PE 54.2911 |
Fairly Valued
Today
Please note that Emcure Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Emcure Pharmaceuticals is based on 3 months time horizon. Increasing Emcure Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Emcure Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emcure Stock. However, Emcure Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1420.7 | Real 1404.94 | Hype 1419.75 | Naive 1394.26 |
The real value of Emcure Stock, also known as its intrinsic value, is the underlying worth of Emcure Pharmaceuticals Company, which is reflected in its stock price. It is based on Emcure Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Emcure Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Emcure Pharmaceuticals helps investors to forecast how Emcure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emcure Pharmaceuticals more accurately as focusing exclusively on Emcure Pharmaceuticals' fundamentals will not take into account other important factors: Emcure Pharmaceuticals Company Current Valuation Analysis
Emcure Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Emcure Pharmaceuticals Current Valuation | 295.8 B |
Most of Emcure Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emcure Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Emcure Pharmaceuticals has a Current Valuation of 295.8 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers - Specialty & Generic industry. The current valuation for all India stocks is significantly lower than that of the firm.
Emcure Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emcure Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Emcure Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Emcure Pharmaceuticals by comparing valuation metrics of similar companies.Emcure Pharmaceuticals is rated below average in current valuation category among its peers.
Emcure Fundamentals
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 295.8 B | ||||
| Shares Owned By Insiders | 86.77 % | ||||
| Shares Owned By Institutions | 3.53 % | ||||
| Price To Book | 9.39 X | ||||
| Price To Sales | 3.92 X | ||||
| Revenue | 69.17 B | ||||
| EBITDA | 12.05 B | ||||
| Book Value Per Share | 162.97 X | ||||
| Earnings Per Share | 26.38 X | ||||
| Target Price | 1575.0 | ||||
| Market Capitalization | 270.98 B |
About Emcure Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Emcure Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emcure Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emcure Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Emcure Stock
Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.